Hawaii Cellular Therapy and Transplant Laboratory

Analysis

Hawaii Cellular Therapy and Transplant Laboratory is a registered charity in United States, based in Honolulu, HI. It received its IRS tax-exemption ruling in September 2014, 12 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a supporting organisation (type i) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Hawaii Cellular Therapy and Transplant Laboratory reported income of $235k and spending of $476k, spending 203% of what it took in. Across the 4 years on record, from June 2020 to June 2023, income fell from $2.4m to $235k (-90%), an average of -54% a year. The sharpest change came in the year to June 2022, when income dropped by 85%. Over the whole period it spent 114% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Hawaii Cellular Therapy and Transplant Laboratory sits at the 43rd percentile: it is larger than about 43% of them. Against every charity in United States with reported income it ranks in the 57th percentile, and in the 56th percentile within HI. Charities of a similar size with the same main cause include Community Cancer Education Inc ($234k), Peer Coalition Inc ($235k) and In Jesus Name Medical Ministry ($234k).

On its Form 990 for the period ending June 2023, revenue came from program service revenue 103% of the total. Compensation of current officers, directors and key employees was $81k (17% of expenses). Other salaries and wages came to $189k. At year end it held assets of $737k against liabilities of $18k, net assets of $719k. It reported 7 employees.